netFormulary NHS
Lancashire and South Cumbria
Formulary
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Section
Notes:

The majority of systemic anti-cancer therapies are not listed in this formulary as they are included in either the Lancashire and South Cumbria Cancer Alliance SACT protocols or the Cancer Drugs Fund list, produced by NHSE. 
 Useful Links
Link   LSC Breast Chemotherapy Protocols
Link   NHSE: National Cancer Drugs Fund list
Link   NICE NG122 : Lung cancer: diagnosis and management
Link   NICE NG224: Melanoma: assessment and management
Link   NICE NG47: Haematological cancers: improving outcomes
Link   NICE NG52: Non-Hodgkin’s lymphoma: diagnosis and management
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
08.01.02 Anthracyclines and other cytotoxic antibiotics (2,0)
08.01.03 Antimetabolites (4,0)
spacespace Imatinab (0,0)
spacespace Panitumumab (0,0)
08.02 Drugs affecting the immune response (1,0)
spacespace Immunosuppressant therapy (2,0)
08.02.01 Antiproliferative immunosuppressants (2,0)
08.02.02 Corticosteroids and other immunosuppressants (7,0)
08.02.03 Anti-lymphocyte monoclonal antibodies (4,0)
08.02.04 Other immunomodulating drugs (5,0)
spacespace Interferon Alfa (2,0)
spacespace Interferon beta (3,0)
spacespace Interferon gamma (0,0)
spacespace BCG bladder instillation (1,0)
spacespace Canakinumab (0,0)
spacespace Dimethyl fumarate (0,0)
spacespace Fingolimod (0,0)
spacespace Glatiramer acetate (1,0)
spacespace Histamine (0,0)
spacespace Lenalidomide, pomalidomide, and thalidomide (0,0)
spacespace Natalizumab (1,0)
spacespace Teriflunomide (0,0)
08.03 Sex hormones and hormone antagonists in malignant disease (0,0)
08.03.01 Oestrogens (2,0)
08.03.02 Progestogens (3,0)
08.03.03 Androgens (0,0)
08.03.04 Hormone antagonists (0,0)
08.03.04.01 Breast cancer (5,0)
spacespace Gonadorelin analogues (1,0)
spacespace Anti-androgens (5,0)
08.03.04.03 Somatostatin analogues (3,0)
netFormulary